State of Wisconsin Investment Board’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

State of Wisconsin Investment Board’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-62,400	Closed	-$257K	–	2099
2020 Q4	$257K	Sell	62,400 -9,900	-14%	-$57.1K	﹤0.01%	1910
2020 Q3	$391K	Buy	72,300 +56,800	+366%	+$327K	﹤0.01%	1562
2020 Q2	$104K	Buy	15,500 +3,300	+27%	+$16.1K	﹤0.01%	1631
2020 Q1	$39K	Buy	+12,200	New	+$65K	﹤0.01%	1685
2019 Q3	–	Sell	-14,100	Closed	-$54K	–	1590
2019 Q2	$54K	Buy	+14,100	New	+$46.9K	﹤0.01%	1531

Other funds holding RVLP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State of Wisconsin Investment Board's RVLP Position: Q1 2021 in Review

State of Wisconsin Investment Board sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2021, closing a stake of 62,400 shares — an estimated $257K sold.

State of Wisconsin Investment Board first reported a position in RVLP in Q2 2019 and held it in 5 quarters. The position peaked at $391K in Q3 2020. 55 funds tracked by Wall St. Rank hold RVLP as of Q1 2021.

State of Wisconsin Investment Board reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 62,400 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2021, an estimated $257K.
State of Wisconsin Investment Board first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2019 and held it in 5 quarters.
State of Wisconsin Investment Board's RVL Pharmaceuticals plc Ordinary Shares position peaked at $391K in Q3 2020.
55 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2021, filed 17 May 2021.